{
  "symbol": "BMY",
  "data_type": "company_profile",
  "timestamp": "2025-09-19T14:48:39.473814",
  "data": {
    "address": "Route 206 And Province Line Road",
    "alias": null,
    "city": "Princeton",
    "country": "US",
    "currency": "USD",
    "cusip": "110122108",
    "description": "Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 34,100 full-time employees.  The company is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its platforms comprise chemically synthesized or small molecule drugs, including protein degraders; drugs produced from biological processes, called biologics; ADCs, CAR-T cell therapies, and radiopharmaceutical therapeutics. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are also used. Biologics are typically administered through injections or by intravenous infusion. CAR-T cell therapies are administered by intravenous infusion. Its growth portfolio includes Opdivo, Opdivo Qvantig, Orencia, Yervoy, Reblozyl, Opdualag, and others. Its legacy portfolio includes Eliquis, Revlimid, Pomalyst/Imnovid, Sprycel and Abraxane.",
    "employeeTotal": 34100,
    "estimateCurrency": "USD",
    "exchange": "NEW YORK STOCK EXCHANGE, INC.",
    "finnhubIndustry": "Pharmaceuticals",
    "floatingShare": 2033.88,
    "fundamentalFreq": "q",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Pharmaceuticals",
    "gsector": "Health Care",
    "gsubind": "Pharmaceuticals",
    "insiderOwnership": 0.0256,
    "institutionOwnership": 84.1367,
    "ipo": "1980-03-17",
    "irUrl": "https://www.bms.com/investors.html",
    "isin": "US1101221083",
    "lei": "HLYYNH7UQUORYSJQCN42",
    "logo": "https://static2.finnhub.io/file/publicdatany/finnhubimage/stock_logo/BMY.svg",
    "marketCapCurrency": "USD",
    "marketCapitalization": 92815.88070578549,
    "marketcapUSD": 0,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Bristol-Myers Squibb Co",
    "phone": "16092524621",
    "sedol": "2126335",
    "shareOutstanding": 2035.44,
    "state": "NEW JERSEY",
    "ticker": "BMY",
    "usShare": 0,
    "weburl": "https://www.bms.com"
  }
}